Background: To investigate the potential of intravenously administered porcine recombinant interferon-β1a (IFN-β1a) for myocardial protection during acute ischemia-reperfusion (IR) injury in an experimental animal model.
Methods: Twenty-two piglets (mean ± standard deviation, 26.7 ± 1.